EcoDrugPlus

Ensembl ID : YDR039C
Description: -
461 Possible Orthologues:

Title

Ensembl ID : YDR040C
Description: -
461 Possible Orthologues:

Title

Ensembl ID : YDR064W
Description: -
121 Possible Orthologues:

Title

Ensembl ID : YDR155C
Description: -
718 Possible Orthologues:

Title

Ensembl ID : YDR237W
Description: -
91 Possible Orthologues:

Title

Ensembl ID : YDR270W
Description: -
268 Possible Orthologues:

Title

Ensembl ID : YDR368W
Description: -
466 Possible Orthologues:

Title

Ensembl ID : YDR382W
Description: -
29 Possible Orthologues:

Title

Ensembl ID : YDR394W
Description: -
105 Possible Orthologues:

Title

Ensembl ID : YDR408C
Description: -
86 Possible Orthologues:

Title

Ensembl ID : YDR418W
Description: -
104 Possible Orthologues:

Title

Ensembl ID : YDR427W
Description: -
73 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).